What is the share price of Jeevan Scientific Technology Ltd (JSTL) today?
The share price of JSTL as on 18th September 2026 is ₹81.98. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Jeevan Scientific Technology Ltd (JSTL) share?
The past returns of Jeevan Scientific Technology Ltd (JSTL) share are- Past 1 week: -1.23%
- Past 1 month: 1.21%
- Past 3 months: 1.55%
- Past 6 months: 28.97%
- Past 1 year: 107.75%
- Past 3 years: 34.52%
- Past 5 years: -11.40%
What are the peers or stocks similar to Jeevan Scientific Technology Ltd (JSTL)?
The peers or stocks similar to Jeevan Scientific Technology Ltd (JSTL) include:What is the market cap of Jeevan Scientific Technology Ltd (JSTL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Jeevan Scientific Technology Ltd (JSTL) is ₹161.84 Cr as of 18th September 2026.What is the 52 week high and low of Jeevan Scientific Technology Ltd (JSTL) share?
The 52-week high of Jeevan Scientific Technology Ltd (JSTL) is ₹93.90 and the 52-week low is ₹32.85.What is the PE and PB ratio of Jeevan Scientific Technology Ltd (JSTL) stock?
The P/E (price-to-earnings) ratio of Jeevan Scientific Technology Ltd (JSTL) is 140.73. The P/B (price-to-book) ratio is 3.23.Which sector does Jeevan Scientific Technology Ltd (JSTL) belong to?
Jeevan Scientific Technology Ltd (JSTL) belongs to the Health Care sector & Labs & Life Sciences Services sub-sector.How to buy Jeevan Scientific Technology Ltd (JSTL) shares?
You can directly buy Jeevan Scientific Technology Ltd (JSTL) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Jeevan Scientific Technology Ltd
JSTL Share Price
BSE₹81.981.84% (+1.48)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
JSTL Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
JSTL Performance & Key Metrics
JSTL Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 46.64 | 3.23 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 47.20 | 5.92 | 0.48% |
JSTL Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
JSTL Company Profile
Jeevan Scientific Technology Limited is engaged in providing data management services. The Company's segments include Clinical Research Services, Data Management Services and Information Technology Services.
DIVISLAB
PE Ratio
96.91
96.91
1Y Return
53.39%
53.39%
Buy Reco %
60.87
60.87
SYNGENE
PE Ratio
46.83
46.83
1Y Return
43.91%
43.91%
Buy Reco %
62.50
62.50
AARTIPHARM
PE Ratio
42.59
42.59
1Y Return
8.87%
8.87%
Buy Reco %
0.00
0.00
VIMTALABS
PE Ratio
34.78
34.78
1Y Return
23.71%
23.71%
Buy Reco %
0.00
0.00
PE Ratio
27.43
27.43
1Y Return
40.47%
40.47%
Buy Reco %
0.00
0.00
JSTL Forecast
JSTL Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
JSTL
JSTL
Income
Balance Sheet
Cash Flow
Quarterly Normal View
JSTL Income Statement
JSTL Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 11.30 | 12.99 | 11.56 | 12.74 | 10.20 | 9.13 | 12.58 | 19.21 | 21.58 | 18.45 | ||||||||||
Operating & Other expenses | 10.09 | 9.65 | 8.90 | 10.43 | 10.44 | 10.58 | 10.31 | 13.84 | 17.00 | 15.33 | ||||||||||
EBITDA | 1.21 | 3.34 | 2.66 | 2.31 | -0.24 | -1.45 | 2.27 | 5.37 | 4.58 | 3.12 | ||||||||||
| Depreciation/Amortization | 1.64 | 1.51 | 1.49 | 1.48 | 1.77 | 1.74 | 1.69 | 1.60 | 1.61 | 1.70 | ||||||||||
| PBIT | -0.43 | 1.83 | 1.17 | 0.83 | -2.01 | -3.19 | 0.58 | 3.77 | 2.97 | 1.42 | ||||||||||
| Interest & Other Items | 0.33 | 0.33 | 0.45 | 0.43 | 0.55 | 0.54 | 0.55 | 0.54 | 0.41 | 0.44 | ||||||||||
| PBT | -0.76 | 1.50 | 0.72 | 0.40 | -2.56 | -3.73 | 0.03 | 3.23 | 2.56 | 0.98 | ||||||||||
| Taxes & Other Items | -0.03 | 0.41 | 0.48 | 0.29 | -1.25 | -0.63 | 0.12 | 1.81 | 0.96 | 0.44 | ||||||||||
| Net Income | -0.73 | 1.09 | 0.24 | 0.11 | -1.31 | -3.10 | -0.09 | 1.42 | 1.60 | 0.54 | ||||||||||
| EPS | -0.47 | 0.66 | 0.16 | 0.03 | -0.81 | -2.03 | 0.01 | 1.52 | 0.92 | 0.44 |
JSTL Company Updates
JSTL Stock Peers
JSTL Past Performance & Peer Comparison
JSTL Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareLabs & Life Sciences Services
Compare valuation on Screener
Health CareLabs & Life Sciences Services
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Jeevan Scientific Technology Ltd | 140.73 | 3.23 | — |
| Divi's Laboratories Ltd | 96.91 | 14.85 | 0.32% |
| Syngene International Ltd | 46.83 | 3.07 | 0.34% |
| Aarti Pharmalabs Ltd | 42.59 | 3.50 | 0.43% |
JSTL Stock Price Comparison
Compare JSTL with any stock or ETFCompare JSTL with any stock or ETF
JSTL
JSTL Holdings
JSTL Shareholdings
JSTL Promoter Holdings Trend
JSTL Promoter Holdings Trend
Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has decreased by 7.80%
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
JSTL Institutional Holdings Trend
JSTL Institutional Holdings Trend
Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has increased by 1.01%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
JSTL Shareholding Pattern
JSTL Shareholding Pattern
JSTL Shareholding History
JSTL Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing JSTL stock
smallcases containing JSTL stock
Looks like this stock is not in any smallcase yet.
JSTL Events
JSTL Events
JSTL Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
JSTL Dividend Trend
No dividend trend available
JSTL Upcoming Dividends
JSTL Upcoming Dividends
No upcoming dividends are available
JSTL Past Dividends
JSTL Past Dividends
Cash Dividend
Ex DateEx DateSep 21, 2022
Final
Final | Div/Share: ₹1.20
Dividend/Share
₹1.20
Ex DateEx Date
Sep 21, 2022
Cash Dividend
Ex DateEx DateSep 7, 2021
Final
Final | Div/Share: ₹0.50
Dividend/Share
₹0.50
Ex DateEx Date
Sep 7, 2021
JSTL Stock News & Opinions
JSTL Stock News & Opinions
Articles & Videos
Earnings
Earnings
Jeevan Scientific Technology Ltd consolidated sales down 14.14% on year in Q2FY2026, net profit tumbled by 52.72%Jeevan Scientific Technology Ltd share price declined by 2.33% to Rs 78.52 after the company's net profit witnessed a sharp fall of 52.72% to Rs 0.87 crore, while revenue from operations reduced 14.14% to Rs 18.28 crore in Q2FY26 over Q1FY26. The market capitalization of Healthcare Research, Analytics & Technology industry group stocks on BSE stood at Rs 39847.85 crore, retreating 13.17%. It has marginally improved by 2.14% over last one week and heading higher by 9.92% in last one month while the market capitalization of Jeevan Scientific Technology Ltd has softened by 2.39% and 5.67% in the same period respectively. Profit before tax (PBT) of Jeevan Scientific Technology Ltd stood at Rs 0.98 crore in Q2 FY26, plunging by 126.27% year-on-year, and crashing by 61.72% quarter-on-quarter. EBITDA came in at Rs 3 crore, nosediving by 231.75% YoY and tanking 30.67% sequentially. Total expenses eased by 8.39% to Rs 17.03 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 1.71 crore, inching up 5.56% YoY, while employee benefits expense was at Rs 5.74 crore, slipping by 3.85% YoY. For the TTM ended FY26, revenue from operations improved 18.13% to Rs 46.84 crore, while net profit tanked by 104.51% to Rs 0.06 crore, compared to previous TTM. EBITDA soared by 327% to Rs 6.76 crore, and PBT collapsed by 103.13% to Rs 0.05 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 10.07 crore in FY26, as against Rs 2.89 crore in FY25. Jeevan Scientific Technology Ltd jumped 86.46% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 2.83% during the same period.
1 month agoCapital Market - Live
Corporate
Corporate
Jeevan Scientific Tech. announces board meeting dateJeevan Scientific Tech. will hold a meeting of the Board of Directors of the Company on 29 May 2026.
3 months agoCapital Market - Live
Earnings
Earnings
Jeevan Scientific Technology consolidated net profit rises 1190.91% in the December 2025 quarterNet profit of Jeevan Scientific Technology rose 1190.91% to Rs 1.42 crore in the quarter ended December 2025 as against Rs 0.11 crore during the previous quarter ended December 2024. Sales rose 52.44% to Rs 19.07 crore in the quarter ended December 2025 as against Rs 12.51 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales19.0712.51 52 OPM %27.4316.55 - PBDT4.831.87 158 PBT3.230.39 728 NP1.420.11 1191 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Jeevan Scientific Tech. postpones board meetingJeevan Scientific Tech. has postponed the meeting of the Board of Directors which was scheduled to be held on 30 December 2025. The meeting will now be held on 2 January 2026.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Corporate
Jeevan Scientific Tech. to hold board meetingJeevan Scientific Tech. will hold a meeting of the Board of Directors of the Company on 30 December 2025.Powered by Capital Market - Live
8 months agoCapital Market - Live
Earnings
Earnings
Jeevan Scientific Technology reports consolidated net loss of Rs 0.09 crore in the September 2025 quarterNet loss of Jeevan Scientific Technology reported to Rs 0.09 crore in the quarter ended September 2025 as against net profit of Rs 0.24 crore during the previous quarter ended September 2024. Sales rose 8.60% to Rs 12.38 crore in the quarter ended September 2025 as against Rs 11.40 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales12.3811.40 9 OPM %16.7221.93 - PBDT1.722.21 -22 PBT0.030.72 -96 NP-0.090.24 PL Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Corporate
Jeevan Scientific Tech. schedules board meetingJeevan Scientific Tech. will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Corporate
Jeevan Scientific Tech. to convene board meetingJeevan Scientific Tech. will hold a meeting of the Board of Directors of the Company on 15 October 2025.Powered by Capital Market - Live
11 months agoCapital Market - Live
Corporate
Corporate
Jeevan Scientific Tech. schedules AGMJeevan Scientific Tech. announced that the Annual General Meeting(AGM) of the company will be held on 27 September 2025.Powered by Capital Market - Live
1 year agoCapital Market - Live
Earnings
Earnings
Jeevan Scientific Technology reports consolidated net loss of Rs 3.10 crore in the June 2025 quarterNet loss of Jeevan Scientific Technology reported to Rs 3.10 crore in the quarter ended June 2025 as against net profit of Rs 1.09 crore during the previous quarter ended June 2024. Sales declined 31.68% to Rs 8.80 crore in the quarter ended June 2025 as against Rs 12.88 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales8.8012.88 -32 OPM %-20.2325.08 - PBDT-1.993.01 PL PBT-3.731.49 PL NP-3.101.09 PL Powered by Capital Market - Live
1 year agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 4.85%, vs industry avg of 11.38%
Over the last 5 years, market share decreased from 0.4% to 0.29%
Over the last 5 years, net income has grown at a yearly rate of -37.15%, vs industry avg of 8.08%